Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Blood
|
October 26, 2000
High levels of soluble syndecan-1 in myeloma-derived bone marrow: modulation of hepatocyte growth factor activity
C Seidel, M Børset, O Hjertner, et al.
European Journal of Haematology
|
September 21, 2000
Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma
N Abildgaard, H Glerup, J Rungby, et al.
Blood
|
September 25, 2001
Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease
C Seidel, Ø Hjertner, N Abildgaard, et al.
British Journal of Haematology
|
October 16, 1999
Prognostic evaluation in multiple myeloma: an analysis of the impact of new prognostic factors
I Turesson, N Abildgaard, T Ahlgren, et al.
Bone Marrow Transplantation
|
November 11, 2008
The polymorphism IL-1beta T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT
A J Vangsted, T W Klausen, W Ruminski, et al.
Bone Marrow Transplantation
|
June 30, 2015
Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial
P Gimsing, Ø Hjertner, N Abildgaard, et al.
Bone Marrow Transplantation
|
April 14, 2015
Autologous stem cell transplantation versus novel drugs or conventional chemotherapy for patients with relapsed multiple myeloma after previous ASCT
M Grövdal, H Nahi, G Gahrton, et al.
Journal of Hematology & Oncology
|
January 18, 2018
Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel
J Caers, B Paiva, E Zamagni, et al.
Leukemia
|
September 3, 2010
The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group
E Terpos, M A Dimopoulos, O Sezer, et al.
Blood Cancer Journal
|
August 26, 2017
Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group
J Hillengass, L A Moulopoulos, S Delorme, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Blood
|
October 26, 2000
High levels of soluble syndecan-1 in myeloma-derived bone marrow: modulation of hepatocyte growth factor activity
C Seidel, M Børset, O Hjertner, et al.
European Journal of Haematology
|
September 21, 2000
Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma
N Abildgaard, H Glerup, J Rungby, et al.
Blood
|
September 25, 2001
Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease
C Seidel, Ø Hjertner, N Abildgaard, et al.
British Journal of Haematology
|
October 16, 1999
Prognostic evaluation in multiple myeloma: an analysis of the impact of new prognostic factors
I Turesson, N Abildgaard, T Ahlgren, et al.
Bone Marrow Transplantation
|
November 11, 2008
The polymorphism IL-1beta T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT
A J Vangsted, T W Klausen, W Ruminski, et al.
Bone Marrow Transplantation
|
June 30, 2015
Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial
P Gimsing, Ø Hjertner, N Abildgaard, et al.
Bone Marrow Transplantation
|
April 14, 2015
Autologous stem cell transplantation versus novel drugs or conventional chemotherapy for patients with relapsed multiple myeloma after previous ASCT
M Grövdal, H Nahi, G Gahrton, et al.
Journal of Hematology & Oncology
|
January 18, 2018
Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel
J Caers, B Paiva, E Zamagni, et al.
Leukemia
|
September 3, 2010
The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group
E Terpos, M A Dimopoulos, O Sezer, et al.
Blood Cancer Journal
|
August 26, 2017
Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group
J Hillengass, L A Moulopoulos, S Delorme, et al.
Page
of 3